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Clinics 
Age and sex 
64 years old male patient. 
Previous history 
No preleukemia. No previous malignancy. No inborn 
condition of note.  
Organomegaly 
No hepatomegaly, no splenomegaly, enlarged lymph 
nodes (occurence of an organomegaly on January 2011 
with diaphragmatic lymph nodes and tonsil 
infiltration), no central nervous system involvement. 
Blood 
WBC : 14,6X 109/l 
HB : 14,2g/dl 
Platelets : 212X 109/l 
Blasts : with 65% polynuclear neutrophils, 27% 
lymphocytes and 8% monocytes. 45% of the 
lymphocytes present a typical morphology of 
prolymphocytes with enlarged and basophilic 







CD19+, CD5+(high),CD23+(low), CD22+(high),  
CD79b+(high), FMC7+, surface Ig Lambda (high). 
Matutes score = 2 (CD10-, CD20+ high, CD43-, 
CD81+ high) 
Rearranged Ig Tcr: not done. 
Pathology 
Large infiltration of the tonsil by a monomorphic B-cell 
lymphoma with a diffuse growth pattern composed of 
small to medium-sized cells positive for CD5, 
compatible with the diagnosis of mantle cell 
lymphoma, but without expression of cycline D1. 
Electron microscopy: not done. 
Diagnosis 
B cell prolymphocytic leukaemia 
Survival 
Date of diagnosis: 02-2009 (flow cytometry and FISH 
analysis) First conventionnal cytogenetic analysis 
performed on 01-2011. 
Treatment: none to date 
Complete remission :  none 
Treatment related death : no 
Relapse :  N/A 
Status: Alive. Last follow up: 02-2011. 
Karyotype 
Sample: Blood sample 
Culture time: 72 with DSP30+IL2 
Banding: RHG 
Karyotype at Relapse 
46,XY,t(3;17)(q26;q12),t(8;14)(q24;q32)[20] 
 






Atlas Genet Cytogenet Oncol Haematol. 2010; 14(10)   898 
Other molecular cytogenetics results 
FISH analysis using MYC break apart (Abbott-5J9101) 
and IgH break apart (Abbott-5J7301) probes on blood 
sample: confirmation of MYC and IgH rearrangements 
on respectively 89 and 90% of the cells. FISH analysis 
on tonsil sample: confirmation of MYC and IgH 
rearrangements on respectively 80 and 73% of the 
cells. 
Other Molecular Studies 
Results: 
Complementary FISH analysis on initial blood sample 
(02-2009): - using MYC Break apart probe : presence 
of MYC rearrangement in 94% of the cells; - using 
CLL probe set (Abbott-8L5320) : no deletion 17p, no 
deletion 11q, no trisomy12, no deletion 13q. 
 
Typical morphology of prolymphocytes observed on blood sample (MGG staining, x100). 
 
A) Monomorphic lymphoid proliferation with a diffuse growth pattern composed of small to medium-sized cell with slighly irregular nuclear 
contours (HES-stained section, x400 magnifications). 
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B) The lymphoma cells, intermingled with small reactive T cells, strongly express CD5 (immunohistochemistry on paraffin-embedded 
section, x400 magnifications). 
 
Conventional RHG karyotype with the presence of a t(8;14)(q24;q32) [indicated by red arrows] associated with a t(3;17)(q26;q12). 
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FISH metaphase observed on blood sample using MYC break apart probe and showing a split of the fusion signal resulting in the 5'MYC 
signal located on the der(8) and the 3'MYC signal located on the der(14). 
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Interphasic nuclei of tonsil sample observed by hybridization in situ with MYC break apart probe showing a split of the fusion signal in 1 
red and 1 green signals demonstrating the presence of MYC rearrangement. 
 
Comments 
MYC rearrangement in chronic lymphocytic disorder is 
a very rare event (<1 % of CLL) (Lu et al., 2010). The 
presence of the t(8;14) translocation is preferentially 
associated with increased prolymphocytes (Huh et al., 
2008; Merchant et al., 2003), and, indeed, is described 
as a recurrent abnormality in B cell prolymphocytic 
leukaemia (Merchant et al., 2003; Kuriakose et al.,
2004; Crisostomo et al., 2007). In the case reported 
here, two years after the description of 14q32-IgH 
rearrangement on blood sample, the discovery of a 
t(8;14) by conventional karyotype was an important 
clue for the orientation of the diagnosis after reviewing 
cytologic and immunophenotypic data. In addition, 
these data lead to reconsider also the initial 
histopathologic hypothesis of mantle cell lymphoma all 
the more as no t(11;14) translocation as well as non 
hyperexpression of cycline D1 were present. 
Identification of a B cell prolymphocytic leukaemia is 
essential because of the potential rapid evolution with
rising of leucocytes count and the poor response to 
CLL therapies (Swerdlow et al., 2008). 
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